IntelliGenome Receives INVIMA Approval for CRISPR-TB Blood Test and Appoints Velez Lab as Exclusive Distribution Partner in Colombia

HOUSTON and BOGOTÁ, Colombia, June 29, 2026 /PRNewswire/ -- IntelliGenome, Inc., a molecular diagnostics company advancing next-generation tuberculosis detection technologies, today announced that Colombia's National Institute for Food and Drug Surveillance (INVIMA) has granted sanitary...